Natixis Portfolio holdings
Natixis is the wholesale banking subsidiary of the French banking group BPCE, and its businesses have included Natixis Investment Managers, Natixis Wealth Management and Natixis Corporate & Investment Banking. Natixis was created in 2006 by merging the investment banking arms of the Banque Populaire and Caisse d'Epargne groups, which went on to combine as BPCE in 2009. Natixis listed its shares on the stock market in October 2006, with the Caisse d'Epargne and Banque Populaire groups as its main owners. One of its predecessors, Natexis, was formed in 1996 by merging the French foreign trade bank Banque française du commerce extérieur with Crédit national, was taken over by Banque Populaire in 1998 and was renamed Natexis Banques Populaires in 1999. BPCE bought out the remaining public shareholders in 2021 and took Natixis off the stock market, and since then has run those three businesses directly.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$541M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$352M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$180M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$161M |
| 5 |
Humana
HUM
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$230M |
| 2 |
Gilead Sciences
GILD
|
+$154M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$113M |
| 4 |
Micron Technology
MU
|
+$101M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$97.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.52% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 12.31% |
| 4 | Communication Services | 11.21% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Comcast
CMCSA
$88.8B
| $684M | 5.26% |
17,087,250
+14,387,318
| +533% | +$541M |
2016 Q3
5 quarters
|
|
|
2
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $537M | 4.13% |
2,003,889
+1,353,889
| +208% | +$352M |
2017 Q1
3 quarters
|
|
|
3
iShares Russell 2000 ETF
IWM
$78.6B
| $412M | 3.16% |
2,700,000
+1,200,000
| +80% | +$180M |
2015 Q4
8 quarters
|
|
4
State Street Utilities Select Sector SPDR ETF
XLU
$24.2B
| $253M | 1.94% |
9,600,000
| – | – |
2016 Q3
5 quarters
|
|
5
Apple
AAPL
$5.17T
| $246M | 1.89% |
5,806,264
-192,788
| -3% | -$8.06M |
2017 Q3
1 quarter
|
|
6
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.1B
| $211M | 1.62% |
850,305
| – | – |
2015 Q1
11 quarters
|
|
7
Bank of America
BAC
$350B
| $194M | 1.49% |
6,558,293
+2,241,843
| +52% | +$61.8M |
2017 Q3
1 quarter
|
|
8
Goldman Sachs
GS
$267B
| $192M | 1.48% |
753,908
+96,525
| +15% | +$23.7M |
2013 Q2
18 quarters
|
|
|
9
Invesco QQQ Trust
QQQ
$468B
| $167M | 1.29% |
1,068,682
+1,057,754
| +9,679% | +$161M |
2016 Q3
5 quarters
|
|
10
UnitedHealth
UNH
$361B
| $164M | 1.26% |
745,971
+297,434
| +66% | +$63M |
2016 Q3
5 quarters
|
|
11
Boeing
BA
$138B
| $151M | 1.16% |
513,031
+78,638
| +18% | +$21.3M |
2017 Q3
1 quarter
|
|
|
12
Johnson & Johnson
JNJ
$675B
| $151M | 1.16% |
1,078,344
-1,649,710
| -60% | -$230M |
2016 Q3
5 quarters
|
|
13
Pfizer
PFE
$168B
| $148M | 1.14% |
4,314,817
+626,206
| +17% | +$21.4M |
2016 Q2
6 quarters
|
|
14
State Street Energy Select Sector SPDR ETF
XLE
$41.6B
| $141M | 1.09% |
3,906,244
-789,842
| -17% | -$27.2M |
2016 Q3
5 quarters
|
|
15
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.06B
| $137M | 1.06% |
912,500
-137,500
| -13% | -$19.2M |
2016 Q3
5 quarters
|
|
16
Elevance Health
ELV
$92.8B
| $135M | 1.04% |
601,144
-63,184
| -10% | -$13.5M |
2017 Q3
1 quarter
|
|
17
JPMorgan Chase
JPM
$912B
| $133M | 1.02% |
1,244,182
-306,742
| -20% | -$31.1M |
2013 Q2
18 quarters
|
|
18
MPLX
MPLX
$57.5B
| $127M | 0.98% |
3,580,300
-1,827,700
| -34% | -$64.4M |
2016 Q2
6 quarters
|
|
|
19
Humana
HUM
$53.6B
| $126M | 0.97% |
+509,381
| New | +$126M |
2017 Q4
0 quarters
|
|
20
United Parcel Service
UPS
$95.7B
| $125M | 0.96% |
1,052,685
+934,082
| +788% | +$110M |
2017 Q2
2 quarters
|
|
21
Union Pacific
UNP
$180B
| $119M | 0.92% |
891,070
+851,404
| +2,146% | +$103M |
2016 Q3
5 quarters
|
|
22
DuPont de Nemours
DD
$20.6B
| $118M | 0.9% |
651,599
+207,994
| +47% | +$37.5M |
2017 Q2
2 quarters
|
|
23
ExxonMobil
XOM
$680B
| $115M | 0.88% |
1,373,267
+716,450
| +109% | +$59.3M |
2016 Q1
7 quarters
|
|
24
Qualcomm
QCOM
$189B
| $114M | 0.87% |
1,773,246
+966,438
| +120% | +$58.6M |
2015 Q3
9 quarters
|
|
25
Citigroup
C
$206B
| $113M | 0.87% |
1,522,797
+1,481,976
| +3,630% | +$110M |
2013 Q2
18 quarters
|
|
Similar funds
Natixis's Q4 2017 Portfolio in Review
As of Q4 2017, Natixis held 1,403 positions worth $13B, up 20% from $10.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Natixis deployed $1.48B of net new capital in Q4 2017, opening 158 new positions and adding to 272 existing holdings. Its largest new stake was Humana: 509,381 shares worth $126M.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $230M trimmed.
- Natixis's largest Q4 2017 buy was Humana: 509,381 shares worth $126M.
- Natixis added most to Comcast in Q4 2017, an estimated $541M increase.
- Natixis's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $230M.
- Natixis fully exited CR Bard Inc. in Q4 2017, selling an estimated $113M.
- Natixis's ten largest holdings make up 24% of its $13B portfolio in Q4 2017.
- Natixis opened 158 new positions and closed 584 in Q4 2017.
- Natixis's portfolio value rose 20% quarter-over-quarter to $13B.
Based on Natixis's 13F filing for Q4 2017, filed 14 Feb 2018.